Quartz
The Cambridge, Massachusetts-based biotech priced 33.5 million shares at $20 each, topping the $625 million raised by Kailera Therapeutics in April
Go to News Site
Bloomberg Markets
Bloomberg Markets
CNBC
Bloomberg Markets
Yahoo Finance
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz
Quartz